PRESS RELEASE: Placing Update

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

Press Release – 24th December 2019

Sativa Group Plc
(“Sativa” or “the Company” or “the Group”)

Placing Update

On 19th December the Company announced a placing and subscription to raise approximately £1.38 million. Following completion of the fundraising, the Company confirms that a total of 34,500,000 new ordinary shares and 30,825,000 unlisted and non-transferable warrants were issued. Following the fundraising, the Company has a total of 569,189,167 ordinary shares in issue.


For further information please contact:

Henry Lees-Buckley
Chief Executive Officer
Sativa Group PLC
+44 (0) 20 7971 1255

Joseph Colliver
Chief Financial Officer
Sativa Group PLC
+44 (0) 20 7971 1255

Cenkos Securities plc
(NEX Exchange Corporate Adviser)

Corporate Finance
Stephen Keys / Max Gould
+44 (0) 20 7397 8900

Equity Sales
Julian Morse
+44 (0) 20 7397 8900

Allenby Capital Limited (Broker)
Corporate Finance
Nick Naylor / Nicholas Chambers
+44 (0) 20 3328 5656


Equity Sales
Amrit Nahal
+44 (0) 20 3328 5656

Media Enquiries:

Abchurch Communications
Julian Bosdet
+44 (0)207 4594 4070
+44 (0) 7771 663 886

Notes to Editors

Sativa Group plc is the UK’s leading quoted CBD wellness and medicinal cannabis group with three operating subsidiaries and one research entity.

George Botanicals (trading as Goodbody Botanicals) provides CBD products online and to retail markets including pharmacies, wellness stores and grocers. Goodbody Wellness is a high-street retail brand with dedicated CBD wellness stores providing a premium shopping experience to consumers. Tessellate Collective, a division of George Botanicals, is a direct-selling platform servicing consumers at home. Phytovista laboratories provides independent testing of CBD products to both external customers and fellow Group businesses.

Sativa Cultivation and Extraction holds a Controlled Drug licence and cultivates cannabis plants to fulfil its partnership agreement with King’s College London to research the impact of cannabinoids on inflammation and respiratory conditions.

– Ends –

Share on facebook
Share on google
Share on twitter
Share on linkedin

Published on